loadpatents
Patent applications and USPTO patent grants for Fernandez-Montalvan; Amaury Ernesto.The latest application filed is for "macrocyclic fluorine substituted indole derivatives".
Patent | Date |
---|---|
Macrocyclic chlorine substituted indole derivatives Grant 11,447,504 - Thede , et al. September 20, 2 | 2022-09-20 |
Substituted macrocyclic indole derivatives Grant 11,440,923 - Thede , et al. September 13, 2 | 2022-09-13 |
Macrocyclic Fluorine Substituted Indole Derivatives App 20220281891 - Ferrara; Steven J. ;   et al. | 2022-09-08 |
Macrocyclic indole derivatives Grant 11,401,278 - Furst , et al. August 2, 2 | 2022-08-02 |
Macrocyclic fluorine substituted indole derivatives Grant 11,286,263 - Ferrara , et al. March 29, 2 | 2022-03-29 |
Macrocyclic Indole Derivatives App 20210292341 - Furst; Laura ;   et al. | 2021-09-23 |
Macrocyclic Chlorine Substituted Indole Derivatives App 20210277022 - Thede; Kai ;   et al. | 2021-09-09 |
Substituted Macrocyclic Indole Derivatives App 20210269456 - Thede; Kai ;   et al. | 2021-09-02 |
Aryl Annulated Macrocyclic Indole Derivatives App 20210253598 - Thede; Kai ;   et al. | 2021-08-19 |
Macrocyclic Fluorine Substituted Indole Derivatives App 20210079018 - Ferrara; Steven J. ;   et al. | 2021-03-18 |
Antibody Drug Conjugates (adcs) With Nampt Inhibitors App 20200360531 - BOHNKE; Niels ;   et al. | 2020-11-19 |
Furane derivatives as inhibitors of ATAD2 Grant 10,654,818 - Berger , et al. | 2020-05-19 |
Thiazole Compounds Useful As Prmt5 Inhibitors App 20200123147 - BOUCHE; Lea Aurelie ;   et al. | 2020-04-23 |
Substituted benzylindazoles for use as BUB1 kinase inhibitors in the treatment of hyperproliferative diseases Grant 10,604,532 - Hitchcock , et al. | 2020-03-31 |
Substituted Benzylindazoles For Use As Bub1 Kinase Inhibitors In The Treatment Of Hyperproliferative Diseases App 20190284206 - HITCHCOCK; Marion ;   et al. | 2019-09-19 |
Furane Derivatives As Inhibitors Of Atad2 App 20190218196 - BERGER; Markus ;   et al. | 2019-07-18 |
Benzyl substituted indazoles as BUB1 inhibitors Grant 10,350,206 - Mengel , et al. July 16, 2 | 2019-07-16 |
Substituted benzylindazoles for use as Bub1 kinase inhibitors in the treatment of hyperproliferative diseases Grant 10,266,548 - Hitchcock , et al. | 2019-04-23 |
2,3-benzodiazepines Grant 9,890,147 - Siegel , et al. February 13, 2 | 2018-02-13 |
Diaminoheteroaryl Substituted Indazoles App 20170283396 - HILGER; Christoph-Stephan ;   et al. | 2017-10-05 |
Substituted Cycloalkenopyrazoles As Bub1 Inhibitors For The Treatment Of Cancer App 20170275267 - HITCHCOCK; Marion ;   et al. | 2017-09-28 |
Benzyl Substituted Indazoles As Bub1 Inhibitors App 20170273980 - MENGEL; Anne ;   et al. | 2017-09-28 |
Benzyl Substituted Indazoles App 20170275270 - BARFACKER; Lars ;   et al. | 2017-09-28 |
Heteroaryl Substituted Indazoles App 20170275268 - HITCHCOCK; Marion ;   et al. | 2017-09-28 |
Benzyl Substituted Indazoles As Bub1 Kinase Inhibitors App 20170275269 - MENGEL; Anne ;   et al. | 2017-09-28 |
Substituted benzylpyrazoles Grant 9,765,058 - Hitchcock , et al. September 19, 2 | 2017-09-19 |
Substituted Benzylindazoles For Use As Bub1 Kinase Inhibitors In The Treatment Of Hyperproliferative Diseases App 20170260198 - HITCHCOCK; Marion ;   et al. | 2017-09-14 |
Heteroaryl substituted pyrazoles Grant 9,745,285 - Mengel , et al. August 29, 2 | 2017-08-29 |
Heteroaryl substituted pyrazoles Grant 9,682,974 - Mengel , et al. June 20, 2 | 2017-06-20 |
BET protein-inhibiting 5-aryltriazoleazepines Grant 9,663,523 - Schmees , et al. May 30, 2 | 2017-05-30 |
Substituted benzylpyrazoles Grant 9,643,953 - Hitchcock , et al. May 9, 2 | 2017-05-09 |
Heteroaryl Substituted Pyrazoles App 20160326159 - MENGEL; Anne ;   et al. | 2016-11-10 |
Bet-protein-inhibiting Dihydropyridopyrazinones App 20160193206 - SCHMEES; Norbert ;   et al. | 2016-07-07 |
Heteroaryl Substituted Pyrazoles App 20160168130 - HITCHCOCK; Marion ;   et al. | 2016-06-16 |
Diaminoheteroaryl Substituted Pyrazoles App 20160145239 - HILGER; Christoph-Stephan ;   et al. | 2016-05-26 |
Heteroaryl Substituted Pyrazoles App 20160145267 - HITCHCOCK; Marion ;   et al. | 2016-05-26 |
Diaminoheteroaryl Substituted Indazoles App 20160052912 - HILGER; Christoph-Stephan ;   et al. | 2016-02-25 |
3-heteroaryl Substituted Indazoles App 20160046610 - HITCHCOCK; Marion ;   et al. | 2016-02-18 |
Heteroaryl Substituted Indazoles App 20160046604 - HITCHCOCK; Marion ;   et al. | 2016-02-18 |
Pyrrolo- And Pyrazolo-triazolodiazepines As Bet-protein Inhibitors For Treating Hyperproliferative Diseases App 20160009725 - SCHMEES; Norbert ;   et al. | 2016-01-14 |
4-substituted Pyrrolo- And Pyrazolo-diazepines App 20150376196 - SCHMEES; Norbert ;   et al. | 2015-12-31 |
Bet Protein-inhibiting 5-aryl Triazole Azepines App 20150299201 - Schmees; Norbert ;   et al. | 2015-10-22 |
Substituted Cycloalkenopyrazoles As Bub1 Inhibitors For The Treatment Of Cancer App 20150141372 - Hitchcock; Marion ;   et al. | 2015-05-21 |
Substituted Benzylpyrazoles App 20140315934 - Hitchcock; Marion ;   et al. | 2014-10-23 |
Substituted Benzylindazoles For Use As Bub1 Kinase Inhibitors In The Treatment Of Hyperproliferative Diseases App 20140249133 - Hitchcock; Marion ;   et al. | 2014-09-04 |
6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepines App 20140213575 - Schmees; Norbert ;   et al. | 2014-07-31 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.